Paper · 2026 · Open access

Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation

Nitish Kumar*1, Jibin Mathew2, Dipanwita Pal3

Zenodo (CERN European Organization for Nuclear Research) · Published 21 June 2026 · DOI 10.5281/zenodo.20790800

Open full textCite this paper

In brief

“Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation” is a 2026 paper by Nitish Kumar*1, Jibin Mathew2, Dipanwita Pal3, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
1

Abstract

Click chemistry, introduced by Sharpless and colleagues in 2001, has fundamentally transformed the way chemists and biologists construct molecules, probe biological systems, and develop therapeutics. Defined by its hallmark attributes—high yields, exquisite selectivity, mild reaction conditions, and compatibility with aqueous environments—click chemistry has evolved from an elegant synthetic concept into an indispensable technological platform. This comprehensive review systematically examines the mechanistic underpinnings and synthetic scope of the principal click reactions: copper(I)‎ catalyzed azide‎ alkyne cycloaddition (CuAAC), strain‎ promoted azide‎ alkyne cycloaddition (SPAAC), inverse‎ electron‎ demand Diels‎ Alder (IEDDA) reactions involving tetrazines and strained alkenes, Staudinger ligation, oxime and hydrazone conjugation, and thiol‎ ene additions. We critically evaluate their applications across the drug discovery pipeline—from fragment‎ based screening and combinatorial library synthesis to activity‎ based protein profiling (ABPP) and covalent drug design—and across the increasingly strategic arena of bioconjugation, encompassing antibody‎ drug conjugates (ADCs), site‎ specific protein modification, PEGylation, and radiolabelled imaging agents. Special attention is devoted to bioorthogonal click chemistry, which has enabled real‎ time molecular imaging in living organisms and tissue‎ selective prodrug activation. Emerging frontiers including sulfur(VI) fluoride exchange (SuFEx), photoclick chemistry, and click‎ to‎ release strategies are thoroughly discussed. We also address persistent challenges—copper cytotoxicity, pharmacokinetic liabilities of triazole‎ containing drugs, and linker stability in ADCs—and outline translational pathways toward clinical implementation. Collectively, this review underscores click chemistry's transformative role in bridging synthetic chemistry and molecular medicine, and charts a future where precision bioconjugation enables next‎ generation targeted therapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pal3, N. K. J. M. D. (2026). Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800

MLA 9

Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita. “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.20790800.

Chicago

Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita. 2026. “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800.

Harvard

Pal3, N. K. J. M. D. (2026) ‘Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.20790800.

IEEE

N. K. J. M. D. Pal3, “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.20790800.

BibTeX

@article{pal32026click,
  title     = {{Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation}},
  author    = {Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.20790800},
  url       = {https://doi.org/10.5281/zenodo.20790800}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications

  • click chemistry
  • drug discovery
  • bioconjugation
  • copper-catalyzed azide-alkyne cycloaddition
  • strain-promoted azide-alkyne cycloaddition
  • inverse electron demand Diels-Alder reaction
  • Staudinger ligation
  • thiol-ene addition

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Pal3, N. K. J. M. D. (2026). Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Zenodo (CERN European Organization for Nuclear Research): sign in and open the full text from this page.

Who wrote this paper?

Nitish Kumar*1, Jibin Mathew2, Dipanwita Pal3.

What is the DOI of this paper?

10.5281/zenodo.20790800, permanently at https://doi.org/10.5281/zenodo.20790800. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.